Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPO | P05164 | 3/20 | 0.48 |
| ▸ | HTR1D | P28221 | 1/20 | 0.46 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.46 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.46 |
| ▸ | NQO2 | P16083 | 1/20 | 0.46 |
| ▸ | HTR1A | P08908 | 5/20 | 0.45 |
| ▸ | HTR2A | P28223 | 6/20 | 0.44 |
| ▸ | HTR6 | P50406 | 5/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
| ▸ | DRD2 | P14416 | 1/20 | 0.41 |
| ▸ | HTR7 | P34969 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fumaric Acid SCHEMBL8545087 | 0.90 | MTNR1A (0.46) | MPOHTR1DMTNR1AMTNR1BNQO2 | |
| Fumaric Acid SCHEMBL8545085 | 0.90 | MTNR1A (0.46) | MPOHTR1DMTNR1AMTNR1BNQO2 | |
| SCHEMBL8544722 | 0.87 | HTR2A (0.53) | MPOHTR1DMTNR1AMTNR1BNQO2 | |
| SCHEMBL8544580 | 0.84 | MTNR1A (0.47) | MTNR1AMTNR1BNQO2HTR1AHTR2A | |
| SCHEMBL8545111 | 0.83 | MTNR1A (0.53) | MPOMTNR1AMTNR1BNQO2HTR1A | |
| SCHEMBL31244443 | 0.82 | MTNR1A (0.65) | MPOMTNR1AMTNR1BHTR1AHTR2A | |
| SCHEMBL8545108 | 0.81 | MTNR1A (0.55) | MTNR1AMTNR1BNQO2SLC6A4 | |
| SCHEMBL2541508 | 0.80 | HTR2A (0.65) | HTR1DHTR1AHTR2AHTR6HTR7 | |
| SCHEMBL8543450 | 0.77 | HTR1A (0.71) | MPOHTR1DMTNR1AMTNR1BHTR1A | |
| SCHEMBL8543561 | 0.77 | HTR2A (0.46) | MPOHTR1DMTNR1AMTNR1BNQO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0593513-B1 | TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE RECEPTORS OR 5-HT2 RECEPTOR AGONISTES | SMITHKLINE BEECHAM PLC (GB) | 1998-10-28 | — | — | EP | claimed |
| US-5571833-A | TREATMENT OF MIGRAINE, PORTAL HYPERTENSION | SMITHKLINE BEECHAM PLC (GB) | 1996-11-05 | — | — | US | claimed |
| EP-0593513-A1 | TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE RECEPTORS OR 5-HT2 RECEPTOR AGONISTES | SMITHKLINE BEECHAM PLC (GB) | 1994-04-27 | — | — | EP | claimed |
| WO-1993000333-A1 | TRYPTAMINE ANALOGUES, THEIR SYNTHESIS AND THEIR USE AS 5-HT1-LIKE OR 5-HT2 RECEPTOR AGONISTS | SMITHKLINE BEECHAM PLC (GB) | 1993-01-07 | — | — | WO | claimed |